References
- Arafa M, Besheer T, El-Eraky AM, et al. Genetic variants of XRCC1 and risk of hepatocellular carcinoma in chronic hepatitis C patients. Br J Biomed Sci. 2019;76:64–69.
- Laurent-Puig P, Zucman-Rossi J. Genetics of hepatocellular tumors. Oncogene. 2006;25:3778–3786.
- Eskandari E, Dahmadeh T, Dahmadeh F, et al. Lack of relationship between PTEN 32-bp and TP53 16-bp Ins/Del polymorphisms and chronic hepatitis B virus infection. Virus disease. 2017;28:289–294.
- Khalid A, Hussain T, Manzoor S, et al. PTEN: A potential prognostic marker in virus-induced hepatocellular carcinoma. Tumor Biol. 2017;71–10.
- Hashemi M, Rezaei H, Eskandari-Nasab E, et al. Association of promoter methylation and 32-Bp deletion of the pten gene with susceptibility to metabolic syndrome. Mol Med Rep. 2013;7:342–346.
- Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020–1022.
- Ding J, Gao Y, Liu R, et al. Association of PTEN polymorphisms with susceptibility to hepatocellular carcinoma in a Han Chinese population. DNA Cell Biol. 2011;30:229–234.
- Li H, Liu F, Zhu H, et al. Association of PTEN gene polymorphisms with liver cancer risk. Int J Clin Exp Path. 2015;8:15198–15203.
- Sze K, Wong K, Chu G, et al. Loss of phosphatase and tensin homolog enhances cell invasion and migration through AKT/Sp-1 transcription factor/matrix metalloproteinase 2 activation in hepatocellular carcinoma and has clinicopathologic significance. Hepatology. 2011;53:1558–1569.
- Zhou J, Li X. Association of PTEN expression with liver function and inflammatory changes in patients with liver cancer after chemotherapy. Oncol Lett. 2018;16:6633–6637.
- Zhang Y, Li RQ, Feng XD, et al. Down-regulation of PTEN by HCV core protein through activating nuclear factor-kappa B. Int J Clin Exp Path. 2014;7:7351–7359.
- Peyrou M, Bourgoin L, Foti M. PTEN in liver diseases and cancer. World J Gastroenterol. 2010;16:4627–4633.
- Mirmohammadsadegh A, Marini A, Nambiar S, et al. Epigenetic silencing of the PTEN gene in melanoma. Cancer Res. 2006;66:6546–6552.
- Yu J, Ni M, Xu J, et al. Methylation profiling of twenty promoter CpG islands of genes which may contribute to hepatocellular carcinogenesis. BMC Cancer. 2002;2:29.
- Wang L, Wang W, Zhang Y, et al. Epigenetic and genetic alterations of PTEN in hepatocellular carcinoma. Hepatol Res. 2007;37:389–396.